The Norse Eight trial was part of the data requested by the FDA after the agency rejected the BLA for the company’s Lytenava last year.
Workday gave weaker-than-anticipated guidance for fiscal 2025 subscription services revenue, sending shares tumbling.
The firm, which has headquarters in Silicon Valley and Guangzhou, China, makes tech that can turn cars into self-driving vehicles.
Autodesk reported better-than-expected adjusted profit and sales, but shares fell as the design software maker announced a CFO change.
(Bloomberg) -- Credit investors squeezed by the tightest spreads in almost 20 years are opting for bare-bones strategies, creating a boom for Europe’s
Quantum computing promises to revolutionize the way we process information by leveraging the principles of quantum mechanics. It will offer unprecedented
(Bloomberg) -- France’s banking stocks slid as a potential government collapse and deepening political crisis unsettled investors.Most Read from
On Wednesday, the European Commission approved BeiGene Ltd’s (NASDAQ:BGNE) Tevimbra (tislelizumab) in combination with chemotherapy for the first-line
(Bloomberg) -- Trafigura Group has ordered thousands of tons of zinc out of London Metal Exchange warehouses, fueling a rally in prices, according to
Shares of Dell Technologies (DELL) plunged intraday Wednesday after the computer manufacturer report
